Exome Asset Management’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-189,087
Closed -$363K 53
2025
Q1
$363K Sell
189,087
-16,869
-8% -$32.4K 0.32% 47
2024
Q4
$391K Buy
+205,956
New +$391K 0.29% 54